Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary ...

The AHA and ACC issued a guideline on a clinical classification system to define the severity of an acute PE and assist in developing treatment strategies.

An increase in the number of percutaneous coronary interventions does not appear to have resulted in reduced mortality rates, ...

Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life-threatening blood clot that blocks arteries in the lungs, is critical. Comprehensive ...